Research Activities
 Home > Research > Meetings > Presentations
Presentations
 
Meeting Authors Title
48th Annual ICAAC Grussemeyer CA, Friedman JY, Spalding JR, Benjamin DK, Moran C, Reed SD Bloodstream Infection with C. Albicans and Non-albicans Associated with High Economic and Mortality Burden among Children and Adults
  Walter EB, Swamy GK, Allred N, Hellkamp AS, Dolor RJ Influenza Immunization of Household Contacts of Newborns in the Hospital Setting
  E B Walter Jr, Y Zhu, K Neuzil, J Englund Influenza Immunization of Household Contacts of Newborns in the Hospital Setting
The 64th Deming Conference on Applied Statistics Cosmatos D and Chow SC Statistics in Tranlational Medicine
62nd High Blood Pressure Conference Hester W, Inrig JK, Szczech L, Svetkey LP, Patel UD Lack of Association Between Chronic Kidney Disease and Wide Pulse Pressure Among Adults in the United States
  Patel U, Hester W, Inrig JK, Peralta CA, Shlipak MG, Szczech L, Svetkey L. The Paradox Between Treatment and Control of Hypertension Among Adults with Chronic Kidney Disease in the United States
2008 National State of the Science Congress Bailey D, Barroso J, Muir A, McHutchison J, Patel K, Jezsik J, Goacher E, Richmond J, Sloane R. Trajectories Of Illness Uncertainty And Fatigue In Patients With Chronic Hapatitis C (CHC) Undergoing Watchful Waiting
17th Annual ICSA Applied Statistics Symposium Chow SC and Pong AP Issues on sample size calculation in clinical research
2008 Society of Nuclear Medicine Piccini JP, Horton J, Shaw LK, Al-Khatib S, Iskandrian A, Borges-Neto S SPECT myocardial perfusion imaging is a strong predictor of sudden cardiac death in patients with coronary artery disease
2008 AHRQ PBRN National Research Conference Kemper AR, Sloane P, Dolor R. Community and Clinician Partnership for Prevention
  Dolor RJ, Touchette D, Masica A, Schumock GT, Smith SR. Evaluation of a Medication Therapy Management Program Modeled on Patient Safety in Medicare Beneficiaries at High Risk of Adverse Drug Events
  Dolor RJ, Bigger JT, Bakken S, Szilagyi PG, Fiscella K, Schrader LM, Warner D Pilot testing of the National Clinical Research Associate Model within CTSA institutions
29th SCT Annual Meeting Chow SC Two-stage adaptive design with different study endpoints
HRS 2008 Scientific Sessions Daniel Haithcock, Kevin Jackson, Donald Hegland, Lori Phillips, R.N., Joseph Rybicki, Tristram D. Bahnson Evidence of Cardiac Autonomic Ganglion Cross-talk in a Patient with Inappropriate sinus Tachycardia
  Donald Hegland, G. Burkhard. Mackensen, Daniel H. Katz, Kevin P. Jackson,Danny Rivera, Tristram D. Bahnson Feasibility of Real-time 3D Transesophageal Echocardiography to Image the Ligamenet of Marshall and Guide Catheter Ablation for Atrial Fibrillation
DDW 2008 Schiff E, Poordad F, Jacobson I, Flamm S, Bacon B, Lawitz E, Gordon S, McHutchison J, Ghalib R, Poynard T, Sulkowski M, Trepo C, Rizzetto M, Zeuzem S, Marcellin P, Mendez P, Brass C, Albrecht J. Role of Interferon Response During Re-Treatment of Null Responders with Boceprevir Combination Therapy: Results of Phase II Trail.
  Sulkowski M, Lawitz E, Shiffman ML, Muir AJ, Galler G, McCone J, Nyberg L, Lee WM, Ghalib R, Schiff E, Galati J, Bacon B, Davis M, Herrine S, Bloomer J, Gibas A, Freilich B, Reindollar R, King J, Rossaro L, Mukhopadhyay P, Noviello S, Pedicone L, Albrecht J, McHutchison J. The Ideal (Individualized Dosing Efficacy Versus Flat Dosing To Assess Opitmal Pegylated Interferon Therapy) Phase IIIB Study: Final Results
IPSOR 13th Annual International Meeting CA Grussemeyer, JY Friedman, JR Spalding, DK Benjamin, C Moran, SD Reed C. albicans and C. glabrata bloodstream infections in adults: outcomes and associated costs.
  Lewis EF, Li Y, Pfeffer MA, Solomon SD, Weinfurt KP, Velazquez EJ, Califf RM, Rouleau JL, Kober L, White H, Schulman KA, Reed SD Change in Health-Related Quality of Life Following Non-Fatal Cardiovascular Events in Post-Myocardial Infarction Patients.
  Chou CH, Reed SD, Allsbrook JS, Steele JL, Schulman KA, Alexander MJ Higher inpatient costs among patients with subarachnoid hemorrhage complicated by vasospasm
  Li Y, Friedman JY, O’Neal B, Griffiths RU, Stryjewski ME, Schulman KA, Inrig JK, Fowler VG Jr, Reed SD Inpatient Costs and Clinical Outcomes of S. aureus Bloodstream and Non-bloodstream Infection in Patients with End-Stage Renal Disease: Findings from a Multi-Center Trial.
  Li Y, Friedman JY, Compton KL, Tzeng JP, Schulman KA, Reed SD Is There a Learning Curve Associated with Exercise Training in Patients with Heart Failure?
PAS 2008 Annual Meeting Smith PB, Cohen-Wolkowiez M, Benjamin DK, Cotten CM, Clark RH, Benjamin DK Jr. Late Onset Sepsis in the Neonatal Intensive Care Unit.
  DK Benjamin Jr. BJ Stoll, R Goldberg, TJ Walsh for the NICHD Neonatal Research Network Neonatal Candidiasis: Epidemiology, Clinical Judgment, and Outcomes
  Wade KC, Wu D, Kaufman DA Ward RM Benjamin DK Hoppu K Adamson PI Gastonguay M, and Barrett JS On behalf of the NICHD Pediatric Pharmacology Research Unit Network Population Pharmacokinetics of Fluconazole in Young Infants
  Wade K and Benjamin DK Jr. on behalf of the NICHD Pediatric Pharmacology Research Unit Network Novel Opportunistic Trial Design to Facilitate Phase 1 Pharmacokinetic Drug Studies in Neonates
  Walter EB, Dolor RJ, Rowe-West B, Chmielewski K, Kretsinger K, and Allred
NJ
Cocooning infants: Tdap Immunization for New Parents in the Pediatric
Office
  Smith PB, Walsh TJ, Hope W, Takada A, Kovanda L, Kearns GL, Kaufman D, Sawamoto T, Buell DN, Benjamin DK Jr. Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates.
  Katakam LI, Cotten CM, Goldberg RN, Dang CN, Smith PB Indomethacin vs. Ibuprofen for Treatment of Patent Ductus Arteriosus.
  Greenberg R, Smith PB, Clark RH, Benjamin DK Jr. Traumatic Lumbar Punctures in Young Infants: Test Performance of CSF WBC Count.
  Cohen-Wolkowiez M, Smith PB, Benjamin DK, Cotten CM, Clark RH, Benjamin DK Jr. Early Onset Sepsis in Premature and Term Infants.
  Mitchell TE, Smith PB, Goldberg RN, Hillman S, Millington DS, Cotten CM Correlation of Blood Caffeine Levels Measured by Tandem Mass Spectrometry With Levels from Routine Clinical Laboratory Analysis
  Schultz ED, Tanaka DT, Goldberg RN, Benjamin DK Jr., Smith PB Methicillin-Resistant Staphylococcus aureus Colonization Increases Total Hospital Costs and Prevents New Admissions to the Neonatal Intensive Care Unit
  Bidegain M, Greenberg R, Simmons C, Dang C, Cotten CM, Goldberg RN, Smith PB Vasopressin for Refractory Hypotension in Extremely Low Birth Weight Infants.
APASL 18th Annual Conference Bain V, Kaita K, Marotta P, Yoshida E, Swain M, Bailey R, Patel K, Cronin P, Pulkstenis E, McHutchison J, Subramanian M Albainterferon Alfa-2B Dosed At 4-Week Intervals Demonstrates Clinically Meaningful Antiviral Activity In Chronic Genotype 2 Or 3 Hepatitis C Virus Infection: Results Of A Phase 2 Study.
  Benhamou Y, Zeuzem S, Yoshida E, Bain V, Shouval D, Pianko S, Flisiak R, Rehak V, Grigorescu M, Kaita K, Cronin P, Pulkstenis E, Subramanian M, McHutchison J. Sustained Virologic Response With Albinterferon Alfa-2b Plus Ribavirin Treatment in IFN-Naïve, Chronic Hepatitis C Genotype 1 Patients.
  Nelson D, Rustgi V, Balan V, Sulkowski M, Davis G, Muir A, Lambiase L, Wiesner R, Dickson R, McHutchison J, Cronin P, Pulkstenis E, Subramanian M. Sustained Virologic Response with Albinterferon Alfa-2b/Ribavirin Treatment in Nonresponders to Prior Interferon Therapy.
  Pianko S, Neumann A, Rozenberg L, Zeuzem S, Benhamou Y, McHutchison J, Pulkstenis E, Subramanian M. Early Virologic Response With Albinterferon Alfa-2b Dosed q2wk or q4wk Predicts Similarly High Sustained Virologic Response Rate.
2008 ACR Keystone Pediatric Rheumatology Symposium Schanberg LE, Sandborg C, Barnhart H, Ardoin SP, Yow E, Ilowite NT, Eberhard A, Levy D, Kimura Y, von Scheven E, Silverman E, Bowyer S, Punaro L, Singer NG, Sherry D, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins G, Brunner HI, Jung L, Soep J, Reed A, Mieszkalski KL Associations Between Race/Ethnicity and Clinical SLE Features in the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort
  Schanberg LE, Sandborg C, Ardoin SP, Mieszkalski K, Yow E, Ilowite NT, Eberhard A, Levy D, Kimura Y, von Scheven E, Silverman E, Bowyer S, Punaro L, Singer NG, Sherry D, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins G, Brunner HI, Jung L, Soep J, Reed A, Barnhart H Predictors of Increased Carotid Intima Medial Thickness (CIMT) in the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort.
ARVO 2008 Annual Meeting Csaky KG, Malek G, Herrmann R, Wu F, Saloupis P, Cousins S Intravitreal Injection of TNF-alpha Causes Decreased Neurosensory Retinal Function in the Mouse: A Potential Mechanism of Vision Loss in Neovascular AMD in vivo
EASL 43rd Annual Meeting Rustgi V, Nelson D, Balan V, Sulkowski M, McHutchison J, Fiscells M, Cronin P, Pulkstenis E, Subramanian M Antiviral activity and changes in B-lymphocyte stimulator protein levels during treatment with albinterferon alfa-2b/ribavirin prior interferon therapy non-responders
  Neumann Au, Rozenberg L, Bain VG, McHutchison JG, Pulkstenis E, Subramanian GM Viral kinetics and pharmacodynamics of albinterferon alfa-2b in interferon-treatment naïve patients with chronic hepatitis C genotype 1 infection
  Neumann AU, Zeuzem S, Yoshida E, Benhamou Y, Pianko S, McHutchison J, Pulkstenis E, Subramanian M Predictive value of early antiviral response profile with albinterferon alfa-2b in IFN-naïve , genotype 1 chronic Hepatitis C patients
  Pianko S, Yoshida E, Zeuzem S, Benhamou Y, Bain V, Pulkstenis E, McHutchison J, Subramanian M Health-related Quality of life (HRQoL) with albinterferon alfa-2b plus ribavirin in genotype 1, IFN treatment-naïve, chronic hepatitis C patients
  Manns M, Lindsay KL, Gordon SC, Pockros PJ, Haeussinger D, Hadziyiannia S, Schmidt W, Jacobson I, Barcena R, Schiff E, Shaikh OS, Bacon B, Marcellin P, Smith C, McHutchison JG, Deng W, Pedicone LD, Albrecht JK Sustained Virologic Response to Peginterferon alfa-2b Predicts Long-Term Clearance of HCV at 5 Year Follow-Up
  Afdhal NH, McHutchison JG, Blackman N, Campbell FM, Theodore D Thrombopoietin (TPO) Levels In Patients With Thrombocytopenia And The Effects Of Eltrombopag On Thrombopoietin Levels
  Schiff E, Poordad F, Jacobson I, Flamm S, Bacon B, Lawitz E, Gordon S, McHutchison J, Ghalib R, Poynard T, Sulkowski M, Trepo C, Rizzetto M, Zeuzem S, Marcellin P Boceprevir (B) Combination in Null Responders (NR): Response Dependent on Interferon Responsiveness
  McHutchison J, Everson G, Gordon S, Jacobson I, Kauffman R, McNair L, Muir A PROVE 1: Results From A Phase 2 Study Of Telaprevir With Peginterferon Alfa-2A And Ribavirin Treatment – Naïve Subjects With Hepatitis C
  Lalezari J, Gane E, Rodriquez-Torres M, Reddy R, DeJesus E, Jacobson I, Nelson D, Everson G, Hill G, Beard A, Symonds WT, Berrey MM, McHutchison JG Potent Antiviral Activity of the Nucleoside Inhibitor R7128 in Combination with Standard of Care- Interim Results of R7128 500mg BID
  Afdhal, McHutchison JG, Graham, Wei, Ladin, Hirosawa Double Blind crossover study of RI-001 electrical stimulation on fatigue and inflammation in Hepatitis C patients
Congress of the German Society for Internal Medicine Tillmann HL Standard therapy of hepatitis C. 114
ACC 57th Annual Scientific Sessions Allen LA, Yager JE, Tulsky JA, Bowers MT, Dodson GC, O’Connor CM, Felker GM Factors associated with an optimistic prognostic outlook among heart failure patients
  Allen LA, Turer AT, DeWald T, Gattis-Stough W, Cotter G, O’Connor CM A randomized, open-label, controlled trial of furosemide by continuous infusion versus twice-daily injection for the treatment of acute heart failure.
  Flynn KE, Lin L, Ellis S, Fine L, Pina I, Roll SK, Russell S. Schulman KA, Spertus J, Whellan D, Weinfurt KP Relationships among The Kansas City Cardiomyopathy Questionnaire and clinical measures in patients with heart failure
  Jeffrey S. Berger, Dianne Gallup, Matthew Roe, Christopher B. Granger, Paul W. Armstrong, R. John Simes, Harvey D. White, Frans Van de Werf, Eric J. Topol, Robert A. Harrington, Robert M. Califf, Richard C. Becker, Pamela S. Douglas Sex Differences in Clinical Presentation and Angiographic Data in Acute Coronary Syndromes
  Jeffrey S. Berger, Dianne Gallup, Matthew Roe, Paul W. Armstrong, R John Simes, Harvey D. White, Frans Van de Werf, Eric J. Topol, Christopher B. Granger, Robert A. Harington, Robert M. Califf, Richard C. Becker, Pamela S. Douglas Sex-Based Differences in Mortality Following Acute Coronary Syndromes
  Jeffrey S. Berger, Deepak L. Bhatt, Zhengming Chen, J B Jones, Shamir R. Mehta, Marc S. Sabatine, Steven R. Steinhubl, Eric J. Topol, Peter B. Berger The Relationship Between Sex, Mortality and Cardiovascular Events Among Patients With Established Cardiovascular Disease: A Meta-Analysis
  Piccini JP, Pieper D, Solomon SD, Al-Khatib S, Van de Werf F, Pfeffer MA, McMurray J, Califf RM, Velazquez EJ Predictors of Sudden Cardiac Death Change With Time After Myocardial Infarction: Results From the VALIANT Trial
9th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Piccini JP, Hernandez AF, Dai D, Thomas KL, Lewis WR, Yancy CW, Peterson ED, Fonarow GC Utilization of cardiac resynchronization therapy in patients hospitalized with heart failure.
  Piccini JP, Hernandez AF, Dai D, Thomas KL, Lewis WR, Yancy CW, Peterson ED, Fonarow CG, for the Get With the Guidelines Steering Committee and Hospitals Cardiac resynchronization therapy utilization in patients hospitalized with heart failure
25th Conference on High Frequency Ventilation of Infants & Children Mears S, Smith PB, Rice H, Tracy L, Benjamin J, Cotten CM Use of High-Frequency Jet Ventilation in Infants with Congenital Diaphragmatic Hernia
ASCO 2008 Genitourinary Cancer Symposium Armstrong AJ, Tannock IF, Halabi S, De Wit R, Eisenberger M The relationship of body mass index and serum testosterone levels with disease outcomes in men with castration-resistant metastatic prostate cancer
  Armstrong AJ, Febbo PG, Creel P, Morris K, Madden J, Turnbull J, Dewhirst M, Major N, George DJ A Phase II Study of RAD001 in Men with Hormone Refractory Metastatic Prostate Cancer
SCCM 37th Critical Care Congress Granger C, Katz J, Kleinschmidt K, Gore JM, Wyman A, Anderson FA, on behalf of the STAT Investigators Acute Severe Hypertension is Associated with High Morbidity and Mortality: Interim Results from the STAT Registry
Past Meetings: 2007
HFSA Scientific Sessions 2007 Allen LA, Rogers, JG, Warnica JW, DiSalvo TG, Hasan M, Tasissa G, O’Connor CM, Stevenson LW, on behalf of the ESCAPE Investigators and Coordinators Who ESCAPED from Randomization to Receive A Pulmonary Artery Catheter? Characterization of the ESCAPE Registry.
  Allen LA, Beth D Weatherley, Olga Milo-Cotter, Gerasimos Filippatos, Leonardo H Reisen, Daniel R Bensimhon, Eduardo G Gronda, Paolo Colombo, G. Michael Felker, Benedetta Fontanella, Christopher M O'Connor, Gadi Cotter, Howard Dittrich, Marco Metra and Eric J Velazquez The Natural Course of Symptoms and Signs During Hospitalization for Acute Heart Failure: The Measure-HF Registry.
2007 CNS Annual Meeting Chou C, Reed SD, Allsbrook JS, Steele JL, Schulman KA, Alexander MJ. Incremental Cost of Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage (SAH).
9th Annual IPOS World Congress Jeffery DD, Reeve BB, Tzeng J, Weinfurt KP, Flynn KE, Keefe FJ, Porter LS, Hahn EA, Cella D, and the PROMIS Sexual Function Subcommittee The Sexual Function Domain of the NIH PROMIS: A Preliminary Report.
  Flynn KE, Tzeng J, Jeffery DD, Reeve BB, Weinfurt KP, and the PROMIS Sexual Function Subcommittee. Conceptualizations of Sexual Functioning and Intimacy Among Cancer Sufferers and Survivors.
  Flynn KE, Weinfurt KP, Seils DM, Burnett CB, Schulman KA, Meropol NJ. Decisional Conflict Among Patients Who Accept or Decline Participation in Phase I Oncology Studies.
47th Annual ICAAC Smith PB, Walsh TJ, Hope W, Takada A, Kovanda L, Kearns GL, Kaufman D, Sawamoto T, Buell DN, Benjamin DK Jr. Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates.
  Chu VH, Woods CW, Miro JM, Hoen B, Cabell CH, Pappas PA, Federspiel J, Athan E, Stryjewski ME, Nacinovich F, Marco F, Levine DP, Elliott TS, Fortes CQ, Tornos P, Gordon DL, Utili R, Delahaye F, Corey GR, Fowler VG, Jr., for the ICE-PCS Study Group. Emergence of Coagulase Negative Staphylococci as a Cause of Native Valve Endocarditis.
  Corey, GR Future Approaches to Therapy for MRSA
World Congress of Dermatology Olsen, Elise A. ISCL/EORTC Proposal For a Revision to the Staging and Classification System of MF/SS
  Olsen, Elise A. Mycosis fungoides/Sezary Syndrome: the summary report of ISCL/EORTC meeting
  Olsen, Elise A. Minoxidil, anthralin, topical and intralesional steroids
  Olsen, Elise A. Female pattern hair loss
21st Annual NACF Conference Friedman JY, Hardy C, Morgan-Dewitt E, Reed SD. Pattersns of antibiotic use for patients with mild cystic fibrosis.
FDA Science Day Benjamin DK Jr., Smith PB, Jadhav P, Gobburu JV, Murphy MD, Hasselblad V, Baker-Smith C, Califf RM, Li JS Pediatric Antihypertensive Trial Failures: Analysis of Endpoints and Dose Range.
45th Annual IDSA Lalani T, Chu VH, Friedman JY, Reed SD, Griffiths RI, Crosslin DR, Masselink LE, Kaye KS, Kanafani ZA, Corey GR, Fowler VG, Jr. Clinical Characteristics and Outcomes of Patients with Staphylococcus aureus Bacteremia and Orthopedic Device Infections.
  Ravi J, McHutchison JG, Patel K, Qiang G, Diehl A. Investigations of Mechanisms
ACEP Research Forum 2007 Clem KJ, Glickman SW, Shah A, Finkel MA, Cairns CB, Pietrobon R, Promes SB. Identification of factors that enhance career satisfaction among female emergency medicine physicians.
  Chandra A, Cairns CB, Peakcock FA, McCord JM, Gibler B, Peterson ED, Roe M. Society of Chest Pain Centers accreditation improves ACC/AHA Guidelines compliance for NSTEMI
  Glickman SW, Peterson EA, Chandra A, Schulman KA, Cairns CB Delays in ED fibrinolytic therapy as primary reperfusion therapy for ST-elevation acute myocardial infarction.
  Thornton VL, De Castro LM, Glickman SW, Vanhorn C, Cairns CB. Patient-controlled analgesia for sickle cell patients in the emergency department results in early pain management and increased patient satisfaction.
  Stanley L, Rau G, Scism M, Freeman D, Anderson A, Molinar G, Glickman SW, Chandra A, Laskowitz D, Cairns CB. Pediatric patients are less likely to be eligible and to consent to participate than adult patients in an acute brain injury study.
  Barrett JA, Glickman SW, Caram LB, Woods CW, Freeman D, Oien C, Anderson A, Molinar G, Suarez J, Cairns CB. Utility of triage heart rate and shock index in predicting infection in emergency department patients with systemic inflammatory response syndrome criteria.
  Chandra A, Limkakeng Jr. AT, Glickman SW, Hocker M, Clem KJ, Cairns CB. Diagnostic accuracy of pneumonia and timing to antibiotic differ in geriatric patients with pneumonia.
  Limkakeng Jr,. AT, Chandra A, Glickman SW, Cairns CB. Unsuspected pulmonary embolism in observation unit patients.
2007 ACG Annual Scientific Meeting Smith A, Wolf A, Patel K. Encapsulating Peritoneal Sclerosis.
29th Annual SMDM Meeting Sanders GD, Galhenage SP, Patel K, Schulman KA, McHutchison JG Modeling the Potential Cost-Effectiveness of Adding a Novel STAT-C Agent to Current Standard Therapy in Patients With Genotype 1 Chronic Hepatitis C Infection.
  Weinfurt KP, Seils DM, Tzeng JP, Astrow AB, Schulman KA, Meropol NJ. Varieties of "Don't Know" in Expectations of Benefit Among Patients Entering Early-Phase Oncology Trials.
2007 AASLD 58th Annual Meeting Rochon, J., Rosson, R, Seeff, L, et al A prospective study of the reliability of the RUCAM for assessing causality in Drug-Induced Liver Injury.
  Galhenage SP, Sanders GD, Patel K, Schulman A, McHutchison JG. Modeling the potential cost-effectiveness of adding a novel STAT-C agent to current standard therapy in patients with genotype 1 chronic hepatitis C infection.
  Nelson DR, Rustgi VK, Balan V, Sulkowski M, Davis GL, Muir A, Lambiase L, Dickson RC, Wiesner RH, McHutchison JG, Pulkstenis E, Cronin P, Subramanian GM Sustained Virologic Response with albinterferon alfa-2b/ ribavirin treatment in prior interferon therapy non-responders.
  Zeuzem S, Yoshida EM, Benhamou Y, Bain VG, Shouval D, Pianko S, Flisiak R, Grigorescu M, Rehak V, Kaita KD, Cronin P, Pulkstenis E, Subramanian GM, McHutchison JG. Sustained Virologic Response rates with albinterferon plus ribavirin treatment in IFN-naive, chronic hepatitis C genotype 1 patients.
  Jaconson IM, Everson GT, Gordon SC, Kauffman R, McNair L, Muir A, McHutchison JG. Interim Analysis Results from a Phase 2 Study of telaprevir with Peginterferon alfa-2A Ribavirin in Treatment-naive Subjects with hepatitis C.
  Rodriguez-Torres M, Lawitz EJ, McHutchison JG. Final Results of Patients Treated with Peg-interferon-Alfa-2A (Peg-IFN) and Ribavirin (RBV) Follow -on Therapy After 28-Day Treatment with the Hepatitis C Protease Inhibitor Telaprevir (VX-950), Peg IFN and RBV.
  Schiff ER, Everson GT, Tsai N, Bzowei NH, Gish RG, McHutchison JG, Jacobson IM, Tong MJ, Jensen DM, Lauer GM, Cruickshank S, Ferraro J, Haller A, Duke R, Rodell T, Apelian D. HCV-Specific Cellular Immunity, RNA Reductions, and Normalization of ALT in Chronic HCV Subjects after Treatment with GI-5005, a Yeast-Based Immunotherapy Targeting NS3 and Core: A Randomized Double-Blind, Placebo Controlled Phase 1b Study.
  Patel K, McHutchison JG, Goodman ZD, Theodore D, Webster A, Schultz M, Stancil B, Gartland M, Gardner S. Correlation between liver biopsy and FibroSURE during screening for a Phase II study to assess the antifibrotic activity of Farglitizar in chronic hepatitis C infection.
  Pianko S, Yoshida EM, Zeuzem S, Benhamou Y, Bain VG, Pulkenstenis E, McHutchison JG, Subramanian GM. Favorable quality of life (QoL) with albinterferon alfa-2b plus ribavirin in genotype 1, IFN- naive, chronic hapatitis C (CHC) patients.
  Yoshida EM, Kaita KD, Zeuzem S, Torbenson M, Pulkstenis E, McHutchison JG, Subramanian GM. Prospective comparison of two commercial non- invasive fibrosis serum marker panels( FibroSURE and FibroSpect II) during interferon-based combination therapy in chronic HCV genotype1.
  Reddy R, Rodriguez - Torres M, Gane E, Robson R, Lalezari J, Everson GT, DeJesus E, McHutchison JG, Vargas HE, Beard A, Rodriguez CA, Hill GZ, Symonds W, Berrey M. Antiviral Avtivity, Pharmacokinetics, Safety, and Tolerability of R7128, A Novel Nucleoside HCV RNA Polymerase Inhibitor, Following Multiple, Ascending, Oral Doses in Patients with HCV Genotype 1 Infection Who have Failed Prior Interferon Therapy
  Afdhal NH, McHutchison JG, Shiffman ML, Rodriguez-Torres M, Dusheiko GM, Sigal S, White S, Blackman N, Campbell F, Theodore D. Eltrobopag Raises Platelet Counts in Two Weeks in Patients with HCV and Significant Thrombocytopenia.
  Zekry A, Walley N, Weale M, Ginsburg G, Goldstein D, McHutchison JG. Polymorphisms in Adrenegic Receptors, Adiponcetin and Adiponcetin Receptors Influence Fibrosis Rates and Response to Therapy in Chronic HCV.
2007 ACR/ARHP Scientific Meeting Morgan DeWitt E, Lin L, Glick H, Schulman K, Lingala B, Reed S Who Receives Biologics For Treatment Of RA?
AMIA 2007 Annual Symposium Eisenstein EL, Lobach DF, Montgomery P, Kawamoto K, Anstrom KJ Evaluating Implementation Fidelity in Health Information Technology Interventions.
  Eisenstein EL, Lobach DF, Montgomery P, Kawamoto K, Anstrom KJ Implementation Fidelity: A Framework for Evaluation in the Health Information Technology Field.
2007 Annual HRPP Conference Sugarman S, Fortune-Greeley A, Hardy C, Lawlor JS. Research Participants’ Reactions to Standard Informed Consent Language
Prostate Cancer Symposium Armstrong AJ, Garrett-Mayer ES, Ou Yang Y, et al. A baseline prognostic model incorporating PSA kinetics in hormone-refractory metastatic prostate cancer.
2007 SBM Annual Meeting & Scientific Sessions Best JL, Siega-Riz AM, Dole N, Everson KR Psychological adjustment and health behaviors in pregnancy by pregravid BMI.
42nd Annual EASL Meeting Poynard T, Schiff E, Terg R, Moreno Otero R, Flamm S, Schmidt W, Berg T, Goncales Jr F, Heathcote J, Diago M, McGarrity T, Maieron A, Reichen J, Tanno H, Brandao C, McHutchison J, Silva M, Bedossa P, Deng W, Mukhopadhyay P, Griffel L, Burroughs M, Brass C, Albrecht J Predictors of Sustained Viral Response (SVR) in the Retreatment of Previous Interferon/ Ribavirin Non-Responders (NR): Results from the Epic3 Program
Pediatric Academic Societies' Annual Meeting Ansong A, Smith PB, Benjamin DK, Clark RH, Li JS, Cotten CM, Mangum B, Wade K, Kaufman DA, Benjamin DK Jr Group B Streptococcal Meningitis: Cerebrospinal Fluid Parameters in the Era of Intrapartum Antibiotic Prophylaxis.
Khunvichai HM Chu, Garg V, McHutchison J, Lawitz E, Rodriguez M, Kieffer T, Alam J Predicting HCV Treatment Duration with an HCV Protease Inhibitor Co-administered with Peg-IFN/RBV by Modeling both Wild-type Virus and Low Level Resistant Variant Dynamics.
20th Annual Southeastern Fracture Symposium 2007 Zura RD, Sabesan V, Nichols LA, Dedmond B, Leach P, Jeray K, Obremskey W, Olson SA, Pietrobon R The Effect of Timing of Definitive Fixation for Tibial Plateau Fractures with Associated Compartment Syndrome on Infection Rates.
     
Site Map Contact Us Links Help Terms of Use © 2003-2008 Duke Clinical Research Institute.